Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Antidepressant, talk therapy fail to beat placebo
Reuters
Thursday, December 22, 2011 - 8:56am
tags:
antidepressants
Chelsea Therapeutics fibromyalgia drug shows promise
Reuters
Thursday, December 22, 2011 - 8:51am
tags:
Chelsea Therapeutics, fibromyalgia, carbidopa
The top 10 biotech deal terminations of 2011
Fierce Biotech
Thursday, December 22, 2011 - 8:00am
tags:
GSK, Targacept, Shire, Renovo, Merck, Addex, Diamyd Medical, JNJ, Janssen Pharmaceuticals, Novartis, PeptImmune, Solvay, Depomed, Eli Lilly, Amylin, Portola Pharmaceuticals, Paratek, Cephalon, ImmuPharma
Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Lung Cancer
Yahoo/Reuters
Thursday, December 22, 2011 - 7:57am
tags:
Geron, lung cancer, brain metastases, GRN1005
Exelixis, Sanofi Agree to Terminate Cancer Collaboration Pact
Bloomberg
Thursday, December 22, 2011 - 7:56am
tags:
Sanofi, Exelixis, cancer
Actavis prepares for end of generic drugs model
Chicago Tribune, IL
Thursday, December 22, 2011 - 6:50am
tags:
generics, Actavis
Pharma outsourcing over one third of trials
Pharma Times, UK
Thursday, December 22, 2011 - 6:48am
tags:
outsourcing, clinical trials
5 Potential Big Movers In Pharma For 2012
Seeking Alpha
Thursday, December 22, 2011 - 6:45am
tags:
CytoSorbents, Dendreon, Lpath, SIGA technologies, Prolor
Cancer Drug Developer NewLink Genetics Gets Push From Analysts
Minyanville
Wednesday, December 21, 2011 - 9:12pm
tags:
analysts, NewLink Genetics, pancreatic cancer
SC judge upholds $327M verdict over J&J drug marketing; other state, federal cases pending
Yahoo/AP
Wednesday, December 21, 2011 - 9:10pm
tags:
JNJ, South Carolina, kickbacks, Risperdal
Vivus: analysis links ingredient of weight loss drug Qnexa to greater risk of birth defects
Yahoo/AP
Wednesday, December 21, 2011 - 9:09pm
tags:
Qnexa, birth defects, Vivus
J&J Pulls 12 Million Bottles of Motrin That May Dissolve Slowly
Bloomberg
Wednesday, December 21, 2011 - 9:08pm
tags:
recalls, Motrin, JNJ
J&J Must Defend Securities-Fraud Lawsuit Over Drug Recalls, Judge Rules
Bloomberg
Wednesday, December 21, 2011 - 9:07pm
tags:
JNJ, securities fraud
Interview: Vertex CEO concerned about investors' 'hyper-focus' on hep C
Fierce Biotech
Wednesday, December 21, 2011 - 1:15pm
tags:
hepatitis C, Vertex, Pharma CEOs, Matt Emmens
Merck & Co. Axes Alzheimer Deal with Acumen
Genetic Engineering News
Wednesday, December 21, 2011 - 1:11pm
tags:
Merck, Alzheimer's disease, Acumen, anti-ADDL
Breaking: Sunovion axes sales reps for asthma meds in consolidation move
Fierce Pharma
Wednesday, December 21, 2011 - 12:59pm
tags:
asthma, layoffs, drug reps, Sunovion
False Claims, Off-Label Prescribing & Doctors
Pharmalot
Wednesday, December 21, 2011 - 12:56pm
tags:
off-label, physicians, False Claims Act
Dendreon: Where Do Things Stand On Provenge Reimbursement?
Seeking Alpha
Wednesday, December 21, 2011 - 12:56pm
tags:
Provenge, prostate cancer, Dendreon
Exelixis Licenses PI3K-Delta Program to Merck
Yahoo
Wednesday, December 21, 2011 - 12:55pm
tags:
Merck, Exelixix, P13K-Delta, XL-499
Teva Forecasts $22 Billion Sales in 2012
TheStreet.com
Wednesday, December 21, 2011 - 11:02am
tags:
Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.